Skip to main content
Market intelligence
FTHSector not reported

Faeth Therapeutics, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $1,188,764 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$1,188,764
Corporate buyers
2
Latest transaction
Jul 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 1, 2026Brian C StephensonChief Financial OfficerOpen Market Purchase13,634$23.92$326,128
Jun 26, 2026Brian C StephensonChief Financial OfficerOpen Market Purchase15,641$25.65$401,268
Jun 23, 2026Brian C StephensonChief Financial OfficerOpen Market Purchase17,413$23.31$405,921